Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

56%

5 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 2
3(33.3%)
Phase 3
3(33.3%)
Phase 4
2(22.2%)
Phase 1
1(11.1%)
9Total
Phase 2(3)
Phase 3(3)
Phase 4(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT05517668Phase 2Terminated

Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose

Role: collaborator

NCT04447040Phase 2Completed

Acetaminophen/Naproxen Sodium Dose Ranging Study

Role: lead

NCT03879408Phase 2Completed

Naproxen Sodium/Acetaminophen Proof of Concept Dosing Study

Role: lead

NCT02735122Phase 3Completed

Study of Acetaminophen (ACM) in Post-operative Dental Pain

Role: lead

NCT03772158Phase 1Completed

Cetirizine Chewable Bioequivalence and Food Effect Study

Role: lead

NCT02911961Phase 4Withdrawn

APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors

Role: collaborator

NCT03224403Phase 3Completed

Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental Pain

Role: lead

NCT04132570Phase 4Completed

A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution

Role: lead

NCT03566979Phase 3Completed

Efficacy and Safety Study of a Test Naproxen Sodium 220mg Tablet in Postoperative Dental Pain

Role: lead

All 9 trials loaded